Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy
Publication
, Conference
Prasad, V; Chen, D; Broadwater, G; Reinsmoen, N; Clark, A; Chao, N; Rizzieri, D
Published in: Tissue Antigens
2008
Duke Scholars
Published In
Tissue Antigens
ISSN
0001-2815
Publication Date
2008
Volume
72
Issue
3
Start / End Page
302 / 302
Related Subject Headings
- Immunology
- 1107 Immunology
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Prasad, V., Chen, D., Broadwater, G., Reinsmoen, N., Clark, A., Chao, N., & Rizzieri, D. (2008). Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy. In Tissue Antigens (Vol. 72, pp. 302–302).
Prasad, V., D. Chen, G. Broadwater, N. Reinsmoen, A. Clark, N. Chao, and D. Rizzieri. “Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy.” In Tissue Antigens, 72:302–302, 2008.
Prasad V, Chen D, Broadwater G, Reinsmoen N, Clark A, Chao N, et al. Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy. In: Tissue Antigens. 2008. p. 302–302.
Prasad, V., et al. “Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy.” Tissue Antigens, vol. 72, no. 3, 2008, pp. 302–302.
Prasad V, Chen D, Broadwater G, Reinsmoen N, Clark A, Chao N, Rizzieri D. Impact of inhibitory and activating KIR and HLA ligands in non-myeloablative haplo hematopoietic transplants in patients with high-risk lymphoid malignancy. Tissue Antigens. 2008. p. 302–302.
Published In
Tissue Antigens
ISSN
0001-2815
Publication Date
2008
Volume
72
Issue
3
Start / End Page
302 / 302
Related Subject Headings
- Immunology
- 1107 Immunology
- 1103 Clinical Sciences